Author:
Normant E,Paez G,West K A,Lim A R,Slocum K L,Tunkey C,McDougall J,Wylie A A,Robison K,Caliri K,Palombella V J,Fritz C C
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference31 articles.
1. An WG, Schulte TW, Neckers LM . (2000). The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome. Cell Growth Differ 11: 355–360.
2. Bauer S, Yu LK, Demetri GD, Fletcher JA . (2006). Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor. Cancer Res 66: 9153–9161.
3. Choi YL, Takeuchi K, Soda M, Inamura K, Togashi Y, Hatano S et al. (2008). Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer. Cancer Res 68: 4971–4976.
4. Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Hohfeld J et al. (2001). The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 3: 93–96.
5. Dewaele B, Wasag B, Cools J, Sciot R, Prenen H, Vandenberghe P et al. (2008). Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation. Clin Cancer Res 14: 5749–5758.
Cited by
127 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献